Ying-Chao Lin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ying-Chao Lin has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Cathy Shen Jang Fann
Institute of Biomedical Sciences, Academia Sinica, Taipei 115, Taiwan
2 shared publications - Ie-Bin Lian
Institute of Statistical and Information Science, National Changhua University of Education, Changhua 50007, Taiwan
2 shared publications - Ai-Ru Hsieh
Department of Statistics, Tamkang University, New Taipei City, Taiwan
1 shared publication - Chee-Jen Chang
Research Services Center for Health Information Chang Gung University Taoyuan Taiwan
1 shared publication - Ching-Lin Hsiao
Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan
1 shared publication - Hsin-Chou Yang
Institute of Statistical Science, Academia Sinica
1 shared publication
Latest Publications
- Open Access
- 30 August 2014
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 21 (1) , 88
Identifying rare and common disease associated variants in genomic data using Parkinson's disease as a model
Genome-wide association studies have been successful in identifying common genetic variants for human diseases. However, much of the heritable variation associated with diseases such as Parkinson's disease remains unknown suggesting that many more risk loci are yet to be identified. Rare variants have become important in disease association studies for explaining missing heritability. Methods for detecting this type of association require prior knowledge on candidate genes and combining variants within the region. These methods may suffer from power loss in situations with many neutral variants or causal variants with opposite effects. We propose a method capable of scanning genetic variants to identify the region most likely harbouring disease gene with rare and/or common causal variants. Our method assigns a score at each individual variant based on our scoring system. It uses aggregate scores to identify the region with disease association. We evaluate performance by simulation based on 1000 Genomes sequencing data and compare with three commonly used methods. We use a Parkinson's disease case–control dataset as a model to demonstrate the application of our method. Our method has better power than CMC and WSS and similar power to SKAT-O with well-controlled type I error under simulation based on 1000 Genomes sequencing data. In real data analysis, we confirm the association of α-synuclein gene (SNCA) with Parkinson's disease (p = 0.005). We further identify association with hyaluronan synthase 2 (HAS2, p = 0.028) and kringle containing transmembrane protein 1 (KREMEN1, p = 0.006). KREMEN1 is associated with Wnt signalling pathway which has been shown to play an important role for neurodegeneration in Parkinson's disease. Our method is time efficient and less sensitive to inclusion of neutral variants and direction effect of causal variants. It can narrow down a genomic region or a chromosome to a disease associated region. Using Parkinson's disease as a model, our method not only confirms association for a known gene but also identifies two genes previously found by other studies. In spite of many existing methods, we conclude that our method serves as an efficient alternative for exploring genomic data containing both rare and common variants.
- 30 August 2014
- Published by Springer Nature in Journal of Biomedical Science
- Vol. 21 (1) , 88
Open AccessIdentifying rare and common disease associated variants in genomic data using Parkinson's disease as a model
Genome-wide association studies have been successful in identifying common genetic variants for human diseases. However, much of the heritable variation associated with diseases such as Parkinson's disease remains unknown suggesting that many more risk loci are yet to be identified. Rare variants have become important in disease association studies for explaining missing heritability. Methods for detecting this type of association require prior knowledge on candidate genes and combining variants within the region. These methods may suffer from power loss in situations with many neutral variants or causal variants with opposite effects. We propose a method capable of scanning genetic variants to identify the region most likely harbouring disease gene with rare and/or common causal variants. Our method assigns a score at each individual variant based on our scoring system. It uses aggregate scores to identify the region with disease association. We evaluate performance by simulation based on 1000 Genomes sequencing data and compare with three commonly used methods. We use a Parkinson's disease case–control dataset as a model to demonstrate the application of our method. Our method has better power than CMC and WSS and similar power to SKAT-O with well-controlled type I error under simulation based on 1000 Genomes sequencing data. In real data analysis, we confirm the association of α-synuclein gene (SNCA) with Parkinson's disease (p = 0.005). We further identify association with hyaluronan synthase 2 (HAS2, p = 0.028) and kringle containing transmembrane protein 1 (KREMEN1, p = 0.006). KREMEN1 is associated with Wnt signalling pathway which has been shown to play an important role for neurodegeneration in Parkinson's disease. Our method is time efficient and less sensitive to inclusion of neutral variants and direction effect of causal variants. It can narrow down a genomic region or a chromosome to a disease associated region. Using Parkinson's disease as a model, our method not only confirms association for a known gene but also identifies two genes previously found by other studies. In spite of many existing methods, we conclude that our method serves as an efficient alternative for exploring genomic data containing both rare and common variants.
- Open Access
- 27 May 2008
- Published by Springer Nature in BMC Bioinformatics
- Vol. 9 (1) , 246
Using the longest significance run to estimate region-specific p-values in genetic association mapping studies
Background: Association testing is a powerful tool for identifying disease susceptibility genes underlying complex diseases. Technological advances have yielded a dramatic increase in the density of available genetic markers, necessitating an increase in the number of association tests required for the analysis of disease susceptibility genes. As such, multiple-tests corrections have become a critical issue. However the conventional statistical corrections on locus-specific multiple tests usually result in lower power as the number of markers increases. Alternatively, we propose here the application of the longest significant run (LSR) method to estimate a region-specific p-value to provide an index for the most likely candidate region.Results: An advantage of theLSRmethod relative to procedures based on genotypic data is that only p-value data are needed and hence can be applied extensively to different study designs. In this study the proposedLSRmethod was compared with commonly used methods such as Bonferroni's method and FDR controlling method. We found that while all methods provide good control over false positive rate,LSRhas much better power and false discovery rate. In the authentic analysis on psoriasis and asthma disease data, theLSRmethod successfully identified important candidate regions and replicated the results of previous association studies.Conclusion: The proposedLSRmethod provides an efficient exploratory tool for the analysis of sequences of dense genetic markers. Our results show that theLSRmethod has better power and lower false discovery rate comparing with the locus-specific multiple tests.
- 27 May 2008
- Published by Springer Nature in BMC Bioinformatics
- Vol. 9 (1) , 246
Open AccessUsing the longest significance run to estimate region-specific p-values in genetic association mapping studies
Background: Association testing is a powerful tool for identifying disease susceptibility genes underlying complex diseases. Technological advances have yielded a dramatic increase in the density of available genetic markers, necessitating an increase in the number of association tests required for the analysis of disease susceptibility genes. As such, multiple-tests corrections have become a critical issue. However the conventional statistical corrections on locus-specific multiple tests usually result in lower power as the number of markers increases. Alternatively, we propose here the application of the longest significant run (LSR) method to estimate a region-specific p-value to provide an index for the most likely candidate region.Results: An advantage of theLSRmethod relative to procedures based on genotypic data is that only p-value data are needed and hence can be applied extensively to different study designs. In this study the proposedLSRmethod was compared with commonly used methods such as Bonferroni's method and FDR controlling method. We found that while all methods provide good control over false positive rate,LSRhas much better power and false discovery rate. In the authentic analysis on psoriasis and asthma disease data, theLSRmethod successfully identified important candidate regions and replicated the results of previous association studies.Conclusion: The proposedLSRmethod provides an efficient exploratory tool for the analysis of sequences of dense genetic markers. Our results show that theLSRmethod has better power and lower false discovery rate comparing with the locus-specific multiple tests.